Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1738]
News [4524]
Articles [207]
Editorials [9]
Conferences [164]
elearning [24]
Editor's Choice for June 2016
Prof Gordon McVie - ecancer Editor in Chief
Editor's Choice for June 2016 ( Prof Gordon McVie - ecancer Editor in Chief )
29 Jun 2016
Latest in precision cancer medicine
Prof Richard Schilsky - Chief Medical Officer, ASCO
Latest in precision cancer medicine ( Prof Richard Schilsky - Chief Medical Officer, ASCO )
15 Jun 2016
Advances in first line treatment options for MCL patients
Professor Steven Le Gouill and Professor Simon Rule
Advances in first line treatment options for MCL patients ( Professor Steven Le Gouill and Professor Simon Rule )
11 Jun 2016
The latest in CLL from EHA 2016
Prof Peter Hillmen, Prof Paolo Ghia, Dr Chris Fox and Dr Constantine Tam
The latest in CLL from EHA 2016 ( Prof Peter Hillmen, Prof Paolo Ghia, Dr Chris Fox and Dr Constantine Tam )
11 Jun 2016
An overview of MCL from EHA 2016
Professor Simon Rule and Professor Steven Le Gouill
An overview of MCL from EHA 2016 ( Professor Simon Rule and Professor Steven Le Gouill )
10 Jun 2016
ASCO 2016: Current treatment approaches for advanced prostate cancer
Prof Przemyslaw Twardowski and Prof Gordon McVie
ASCO 2016: Current treatment approaches for advanced prostate cancer ( Prof Przemyslaw Twardowski and Prof Gordon McVie )
7 Jun 2016
ASCO 2016: What is the optimal chemotherapy dosing regimen for prostate cancer?
Prof Charles Ryan and Prof Nick James
ASCO 2016: What is the optimal chemotherapy dosing regimen for prostate cancer? ( Prof Charles Ryan and Prof Nick James )
6 Jun 2016
Global drug pricing: How cost-effective is bevacizumab?
Dr Daniel Goldstein - Emory University, Atlanta, USA
Global drug pricing: How cost-effective is bevacizumab? ( Dr Daniel Goldstein - Emory University, Atlanta, USA )
6 Jun 2016
Update on olaparib in ovarian cancer
Prof Jonathan Ledermann - University College Hospital Medical School, London, UK
Update on olaparib in ovarian cancer ( Prof Jonathan Ledermann - University College Hospital Medical School, London, UK )
6 Jun 2016
ASCO 2016: Accuracy of multi-parametric MRI to predict further investigational...
Prof Nick James and Prof Charles Ryan
ASCO 2016: Accuracy of multi-parametric MRI to predict further investigational biopsy ( Prof Nick James and Prof Charles Ryan )
6 Jun 2016
Impact of precision medicine in refractory malignancies
Prof Maria Schwaederle - University of California, San Diego, USA
Impact of precision medicine in refractory malignancies ( Prof Maria Schwaederle - University of California, San Diego, USA )
6 Jun 2016
Photon vs proton beam therapy: modality in radiotherapy for non-small cell lung...
Dr Madhusmita Behera - Emory University, Atlanta, USA
Photon vs proton beam therapy: modality in radiotherapy for non-small cell lung cancer ( Dr Madhusmita Behera - Emory University, Atlanta, USA )
6 Jun 2016

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation